2024 annual financial data
Xilio Therapeutics 2024 Net margin
Direct answer
Net margin was -918.05%.
Operating income was -60,582,000 USD and net income was -58,241,000 USD.
Operating cash flow was -18,378,000 USD.
Get free Xilio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,344,000 USD
- Operating income
- -60,582,000 USD
- Net income
- -58,241,000 USD
- Operating cash flow
- -18,378,000 USD